Johnson & Johnson COVID-19 vaccine is 66% effective in global trial, but 85% effective against severe disease, company says
Johnson & Johnson COVID-19 vaccine is 66% effective in global trial, but 85% effective against severe disease, company says

Johnson & Johnson’s one-shot vaccine candidate was found to be 85% effective against the most serious symptoms of COVID-19.